Schizophrenia is a severe disorder characterized by psychotic symptoms such as delusions and hallucinations and/or debilitating behavioral symptoms. Schizophrenia afflicts approximately one percent of the population worldwide, making this one of the most widespread diseases known. Despite the severity and prevalence of the disease, the complexity of schizophrenia has hindered efforts to understand its biochemical basis. Recent evidence suggests that DNA expansion may be associated with the disease in a subset of familial cases of schizophrenia in which the disease families display intergenerational """"""""anticipation."""""""" Anticipation is characterized by progressive severity and earlier onset of disease in successive generations and is caused by expansion of simple trinucleotide repeats. It is our hypothesis that if anticipation occurs in a subset of schizophrenics, then the disrupted gene or genes must contain an expansion of a trinucleotide repeat region. Based on this hypothesis, we have developed a novel and powerful method to directly clone gene fragments containing trinucleotide repeats from schizophrenia patients in families that display anticipation. We have patient samples and access to medical records from one of the largest group of schizophrenics assessed for anticipation; we will apply our method to this population. Briefly, novel bead-probes will select for long trinucleotide repeat regions and their associated flanking sequence. The flanking sequence is part of the disrupted gene. The sequence of the flanking regions will be considered """"""""candidates"""""""" from expansion and disease which will be verified by screening two large schizophrenia populations. One is the 16 family group comprising schizophrenia patients associated with anticipation phenotype. The other, larger group is a bank of 750 unrelated schizophrenia patients and 4000 controls. The frequency, distribution and genotype to phenotype analysis of expanded and polymorphic alleles will be assessed using a combination of both data banks. Finally, we will use the flanking sequence as a probe to complete the cloning of any novel genes associated with disease. The clear link between anticipation and expansion has provided new information that we have exploited to clone schizophrenia-related genes. Cloning of at least one gene will likely provide invaluable information towards understanding both the etiology and the biochemical basis for the disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH056207-02
Application #
2890858
Study Section
Molecular, Cellular, and Developmental Neurobiology Review Committee (MCDN)
Program Officer
Moldin, Steven Owen
Project Start
1998-07-01
Project End
2001-06-30
Budget Start
1999-09-01
Budget End
2000-06-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Mayo Clinic, Rochester
Department
Type
DUNS #
City
Rochester
State
MN
Country
United States
Zip Code
55905
Kantarci, O H; Goris, A; Hebrink, D D et al. (2005) IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis. Genes Immun 6:153-61
Kantarci, Orhun H; Hebrink, David D; Achenbach, Sara J et al. (2003) CTLA4 is associated with susceptibility to multiple sclerosis. J Neuroimmunol 134:133-41
Kantarci, Orhun H; Schaefer-Klein, Janet L; Hebrink, David D et al. (2003) A population-based study of IL4 polymorphisms in multiple sclerosis. J Neuroimmunol 137:134-9
Trushina, Eugenia; Heldebrant, Michael P; Perez-Terzic, Carmen M et al. (2003) Microtubule destabilization and nuclear entry are sequential steps leading to toxicity in Huntington's disease. Proc Natl Acad Sci U S A 100:12171-6
Sobell, Janet L; Mikesell, Marci J; McMurray, Cynthia T (2002) Genetics and etiopathophysiology of schizophrenia. Mayo Clin Proc 77:1068-82
Kantarci, Orhun H; Lesnick, Timothy G; Yang, Ping et al. (2002) Myeloperoxidase -463 (G-->A) polymorphism associated with lower risk of lung cancer. Mayo Clin Proc 77:17-22
McMurray, C T (2001) Huntington's disease: new hope for therapeutics. Trends Neurosci 24:S32-8
Kovtun, I V; McMurray, C T (2001) Trinucleotide expansion in haploid germ cells by gap repair. Nat Genet 27:407-11
Wu, X; McMurray, C T (2001) Calmodulin kinase II attenuation of gene transcription by preventing cAMP response element-binding protein (CREB) dimerization and binding of the CREB-binding protein. J Biol Chem 276:1735-41
Weinshenker, B G; Hebrink, D; Kantarci, O H et al. (2001) Genetic variation in the transforming growth factor beta1 gene in multiple sclerosis. J Neuroimmunol 120:138-45

Showing the most recent 10 out of 18 publications